Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Auricularia auricula-judae*, commonly known as the wood ear or jelly ear mushroom, is an edible fungus widely used in traditional Chinese medicine and as a functional food. Its therapeutic potential is primarily attributed to its high concentration of complex polysaccharides, particularly beta-D-glucans. These compounds demonstrate significant immunomodulatory, antioxidant, and anticoagulant activities. In clinical research, extracts of the mushroom have been investigated for their ability to lower blood glucose and cholesterol levels, as well as their potential to inhibit platelet aggregation, which may offer cardiovascular benefits. While not an FDA-approved pharmaceutical, it is a common component in nutraceutical formulations targeting metabolic and circulatory health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on auricularia auricula-judae.